2 completed, 1 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Acute Coronary Syndromes: new trials by email Literature Review of Acute Coronary Syndromes trials Research Report on Acute Coronary Syndromes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Controlled Level EVERolimus in Acute Coronary Syndromes Everolimus, Placebo - Acute Coronary Syndromes | Phase 1 / Phase 2 | Completed | University of Zurich | 150 | 2015-01-08 | 2021-12-03 |
| Drug Interaction Statin BMS-919373, Rosuvastatin, Atorvastatin - Acute Coronary Syndromes | Phase 1 | Completed | Bristol-Myers Squibb | 26 | 2014-03-01 | 2014-08-15 |
| Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary Syndromes clopidogrel, prasugrel - Acute Coronary Syndromes | Phase 1 | Terminated | Eli Lilly and Company | 29 | 2009-10-01 | 2012-03-09 |
Acute Coronary Syndrome (3) · Angina Pectoris (1) · Inflammation (1) · ST Elevation Myocardial Infarction (1)
Cardiovascular Diseases (3) · Heart Diseases (3) · Myocardial Ischemia (3) · Vascular Diseases (3) · Pathological Conditions, Signs and Symptoms (2) · Chest Pain (1) · Infarction (1) · Ischemia (1) · Myocardial Infarction (1) · Necrosis (1) · Neurologic Manifestations (1) · Pain (1) · Pathologic Processes (1) · Signs and Symptoms (1)
Atorvastatin (1) · Clopidogrel (1) · Everolimus (1) · Prasugrel Hydrochloride (1) · Rosuvastatin Calcium (1)
Bristol-Myers Squibb (1) · Eli Lilly and Company (1) · University of Zurich (1)
Germany (2) · Switzerland (1)
Frank Ruschitzka, Professor (1)